GERRATANA, Lorenzo
GERRATANA, Lorenzo
DMED - DIPARTIMENTO DI MEDICINA
1781P Feasibility of an automated data solution for Binary Alignment Map (BAM) files generated through next generation sequencing (NGS) of circulating tumor DNA (ctDNA)
2021-01-01 Pellizzari, L.; Rossi, N.; Verardo, M.; Spizzo, R.; Belletti, B.; Piazza, C.; Puglisi, F.; Gerratana, L.
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer
2021-01-01 Poetto, A. S.; Posocco, B.; Gagno, S.; Orleni, M.; Zanchetta, M.; Iacuzzi, V.; Canil, G.; Buzzo, M.; Montico, M.; Guardascione, M.; Basile, D.; Pelizzari, G.; Alberti, M.; Gerratana, L.; Puglisi, F.; Toffoli, G.
A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases
2023-01-01 Shah, Ami N.; Santa-Maria, Cesar A.; Mukhija, Dhruvika; Shah, Nikita; Kang, Anthony K.; Kumthekar, Priya; Burdett, Kirsten; Chandra, Shruti; Chang, Jenny; Tsarwhas, Dean; Woodman, Jill; Jovanovic, Borko; Gerratana, Lorenzo; Gradishar, William; Cristofanilli, Massimo
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients
2018-01-01 Pelizzari, G.; Gerratana, L.; Basile, D.; Zago, S.; Vitale, M. G.; Bartoletti, M.; Lisanti, C.; Fanotto, V.; Corvaja, C.; Bortot, L.; Liguori, A.; Cinausero, M.; Russo, S.; Andreetta, C.; Bonotto, M.; Mansutti, M.; Minisini, A. M.; Curcio, F.; Fasola, G.; Puglisi, F.
Abstract PD10-01: Impact of ESR1 mutations on Selective Estrogen Receptor Degraders and Modulators: an integrated liquid-biopsy and pharmacodynamics approach
2023-01-01 Gerratana, Lorenzo; Roncato, Rossana; Sturlese, Mattia; Davis, Andrew A.; Velimirovic, Marko; Reduzzi, Carolina; Clifton, Katherine K.; Hensing, Whitney L.; Shah, Ami N.; Dai, Charles S.; D'Amico, Paolo; Medford, Arielle J.; Franzoni, Alessandra; Cucciniello, Linda; Wehbe, Firas; Wander, Seth A.; Belletti, Barbara; Gradishar, William; Behdad, Amir; Damante, Giuseppe; Ma, Cynthia; Puglisi, Fabio; Bardia, Aditya; Cristofanilli, Massimo
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy
2025-01-01 Mastrantoni, L.; Garufi, G.; Giordano, G.; Maliziola, N.; Di Monte, E.; Arcuri, G.; Frescura, V.; Rotondi, A.; Orlandi, A.; Carbognin, L.; Palazzo, A.; Miglietta, F.; Pontolillo, L.; Fabi, A.; Gerratana, L.; Pannunzio, S.; Paris, I.; Pilotto, S.; Marazzi, F.; Franco, A.; Franceschini, G.; Dieci, M. V.; Mazzeo, R.; Puglisi, F.; Guarneri, V.; Milella, M.; Scambia, G.; Giannarelli, D.; Tortora, G.; Bria, E.
Advancing breast cancer clinical management through technological innovation: the potential role of artificial intelligence and integrated care models
2026-01-01 Toss, A.; Bellardita, L.; Botticelli, A.; Caputo, R.; Criscitiello, C.; De Angelis, C.; Dieci, M. V.; Gerratana, L.; Guercini, J.; Lambertini, M.; Mitola, M.; Orlandi, A.; Palazzo, A.; Pistelli, M.; Sano, M. V.; Vernieri, C.; Viale, G.
AI-assisted extraction of opportunistic findings from oncologic CT reports using large language models
2026-01-01 Roitero, Kevin; Nardone, Luigi; Lacitignola, Davide; Lunardi, Riccardo; Vegni, Virginia; Casotto, Laura; Bacchetti, Emiliano; Pavone, Irene; Taveri, Nicolò; Gerratana, Lorenzo; Puglisi, Fabio; Girometti, Rossano; Zuiani, Chiara; Della Mea, Vincenzo; Cereser, Lorenzo
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer
2022-01-01 Roncato, R.; Gerratana, L.; Palmero, L.; Gagno, S.; Poetto, A. S.; Peruzzi, E.; Zanchetta, M.; Posocco, B.; De Mattia, E.; Canil, G.; Alberti, M.; Orleni, M.; Toffoli, G.; Puglisi, F.; Cecchin, E.
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression
2017-01-01 Basile, D.; Cinausero, M.; Iacono, D.; Pelizzari, G.; Bonotto, M.; Vitale, M. G.; Gerratana, L.; Puglisi, F.
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
2018-01-01 Gerratana, L.; Basile, D.; Buono, G.; De Placido, S.; Giuliano, M.; Minichillo, S.; Coinu, A.; Martorana, F.; De Santo, I.; Del Mastro, L.; De Laurentiis, M.; Puglisi, F.; Arpino, G.
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC
2019-01-01 Malfatti, M. C.; Gerratana, L.; Dalla, E.; Isola, M.; Damante, G.; Di Loreto, C.; Puglisi, F.; Tell, G.
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
2019-01-01 Davis, A. A.; Zhang, Q.; Gerratana, L.; Shah, A. N.; Zhan, Y.; Qiang, W.; Finkelman, B. S.; Flaum, L.; Behdad, A.; Gradishar, W. J.; Platanias, L. C.; Cristofanilli, M.
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer
2023-01-01 Peruzzi, Elena; Gerratana, Lorenzo; Montico, Marcella; Posocco, Bianca; Corsetti, Serena; Bartoletti, Michele; Gagno, Sara; Orleni, Marco; De Mattia, Elena; Baraldo, Massimo; Cecchin, Erika; Puglisi, Fabio; Toffoli, Giuseppe; Roncato, Rossana
Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival
2026-01-01 Podany, E. L.; Foffano, L.; Gerratana, L.; Medford, A. J.; Heater, N. K.; Nicolo, E.; Tapiavala, S.; Pontolillo, L.; Putur, A.; Jaber, D. A.; Clifton, K.; Katakam, N.; Addison, S.; Lipsyc-Sharf, M.; Reduzzi, C.; Ademuyiwa, F. O.; Puglisi, F.; Gradishar, W. J.; Ma, C. X.; Bardia, A.; Cristofanilli, M.; Davis, A. A.
BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy
2019-01-01 Mio, Catia; Gerratana, Lorenzo; Bolis, Marco; Caponnetto, Federica; Zanello, Andrea; Barbina, Mattia; Di Loreto, Carla; Garattini, Enrico; Damante, Giuseppe; Puglisi, Fabio
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis
2020-01-01 Bartoletti, M.; Pelizzari, G.; Gerratana, L.; Bortot, L.; Lombardi, D.; Nicoloso, M.; Scalone, S.; Giorda, G.; Baldassarre, G.; Sorio, R.; Puglisi, F.
Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer
2025-01-01 Pasto, B.; Vida, R.; Dri, A.; Foffano, L.; Della Rossa, S.; Gerratana, L.; Puglisi, F.
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis
2020-01-01 Gerratana, Lorenzo; Basile, Debora; Toffoletto, Barbara; Bulfoni, Michela; Zago, Silvia; Magini, Alessandro; Lera, Marta; Pelizzari, Giacomo; Parisse, Pietro; Casalis, Loredana; Vitale, Maria Grazia; Fanotto, Valentina; Bonotto, Marta; Caponnetto, Federica; Bartoletti, Michele; Lisanti, Camilla; Minisini, Alessandro Marco; Emiliani, Carla; Di Loreto, Carla; Fasola, Gianpiero; Curcio, Francesco; Beltrami, Antonio Paolo; Cesselli, Daniela; Puglisi, Fabio
Body mass index impacts adverse events and drug plasma concentration: should dose intensity be included in the palbociclib equation?
2024-01-01 Roncato, Rossana; Puglisi, Fabio; Gerratana, Lorenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1781P Feasibility of an automated data solution for Binary Alignment Map (BAM) files generated through next generation sequencing (NGS) of circulating tumor DNA (ctDNA) | 1-gen-2021 | Pellizzari, L.; Rossi, N.; Verardo, M.; Spizzo, R.; Belletti, B.; Piazza, C.; Puglisi, F.; Gerratana, L. | |
| A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer | 1-gen-2021 | Poetto, A. S.; Posocco, B.; Gagno, S.; Orleni, M.; Zanchetta, M.; Iacuzzi, V.; Canil, G.; Buzzo, M.; Montico, M.; Guardascione, M.; Basile, D.; Pelizzari, G.; Alberti, M.; Gerratana, L.; Puglisi, F.; Toffoli, G. | |
| A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases | 1-gen-2023 | Shah, Ami N.; Santa-Maria, Cesar A.; Mukhija, Dhruvika; Shah, Nikita; Kang, Anthony K.; Kumthekar, Priya; Burdett, Kirsten; Chandra, Shruti; Chang, Jenny; Tsarwhas, Dean; Woodman, Jill; Jovanovic, Borko; Gerratana, Lorenzo; Gradishar, William; Cristofanilli, Massimo | |
| A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients | 1-gen-2018 | Pelizzari, G.; Gerratana, L.; Basile, D.; Zago, S.; Vitale, M. G.; Bartoletti, M.; Lisanti, C.; Fanotto, V.; Corvaja, C.; Bortot, L.; Liguori, A.; Cinausero, M.; Russo, S.; Andreetta, C.; Bonotto, M.; Mansutti, M.; Minisini, A. M.; Curcio, F.; Fasola, G.; Puglisi, F. | |
| Abstract PD10-01: Impact of ESR1 mutations on Selective Estrogen Receptor Degraders and Modulators: an integrated liquid-biopsy and pharmacodynamics approach | 1-gen-2023 | Gerratana, Lorenzo; Roncato, Rossana; Sturlese, Mattia; Davis, Andrew A.; Velimirovic, Marko; Reduzzi, Carolina; Clifton, Katherine K.; Hensing, Whitney L.; Shah, Ami N.; Dai, Charles S.; D'Amico, Paolo; Medford, Arielle J.; Franzoni, Alessandra; Cucciniello, Linda; Wehbe, Firas; Wander, Seth A.; Belletti, Barbara; Gradishar, William; Behdad, Amir; Damante, Giuseppe; Ma, Cynthia; Puglisi, Fabio; Bardia, Aditya; Cristofanilli, Massimo | |
| Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy | 1-gen-2025 | Mastrantoni, L.; Garufi, G.; Giordano, G.; Maliziola, N.; Di Monte, E.; Arcuri, G.; Frescura, V.; Rotondi, A.; Orlandi, A.; Carbognin, L.; Palazzo, A.; Miglietta, F.; Pontolillo, L.; Fabi, A.; Gerratana, L.; Pannunzio, S.; Paris, I.; Pilotto, S.; Marazzi, F.; Franco, A.; Franceschini, G.; Dieci, M. V.; Mazzeo, R.; Puglisi, F.; Guarneri, V.; Milella, M.; Scambia, G.; Giannarelli, D.; Tortora, G.; Bria, E. | |
| Advancing breast cancer clinical management through technological innovation: the potential role of artificial intelligence and integrated care models | 1-gen-2026 | Toss, A.; Bellardita, L.; Botticelli, A.; Caputo, R.; Criscitiello, C.; De Angelis, C.; Dieci, M. V.; Gerratana, L.; Guercini, J.; Lambertini, M.; Mitola, M.; Orlandi, A.; Palazzo, A.; Pistelli, M.; Sano, M. V.; Vernieri, C.; Viale, G. | |
| AI-assisted extraction of opportunistic findings from oncologic CT reports using large language models | 1-gen-2026 | Roitero, Kevin; Nardone, Luigi; Lacitignola, Davide; Lunardi, Riccardo; Vegni, Virginia; Casotto, Laura; Bacchetti, Emiliano; Pavone, Irene; Taveri, Nicolò; Gerratana, Lorenzo; Puglisi, Fabio; Girometti, Rossano; Zuiani, Chiara; Della Mea, Vincenzo; Cereser, Lorenzo | |
| An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer | 1-gen-2022 | Roncato, R.; Gerratana, L.; Palmero, L.; Gagno, S.; Poetto, A. S.; Peruzzi, E.; Zanchetta, M.; Posocco, B.; De Mattia, E.; Canil, G.; Alberti, M.; Orleni, M.; Toffoli, G.; Puglisi, F.; Cecchin, E. | |
| Androgen receptor in estrogen receptor positive breast cancer: Beyond expression | 1-gen-2017 | Basile, D.; Cinausero, M.; Iacono, D.; Pelizzari, G.; Bonotto, M.; Vitale, M. G.; Gerratana, L.; Puglisi, F. | |
| Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype | 1-gen-2018 | Gerratana, L.; Basile, D.; Buono, G.; De Placido, S.; Giuliano, M.; Minichillo, S.; Coinu, A.; Martorana, F.; De Santo, I.; Del Mastro, L.; De Laurentiis, M.; Puglisi, F.; Arpino, G. | |
| APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC | 1-gen-2019 | Malfatti, M. C.; Gerratana, L.; Dalla, E.; Isola, M.; Damante, G.; Di Loreto, C.; Puglisi, F.; Tell, G. | |
| Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer | 1-gen-2019 | Davis, A. A.; Zhang, Q.; Gerratana, L.; Shah, A. N.; Zhan, Y.; Qiang, W.; Finkelman, B. S.; Flaum, L.; Behdad, A.; Gradishar, W. J.; Platanias, L. C.; Cristofanilli, M. | |
| Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer | 1-gen-2023 | Peruzzi, Elena; Gerratana, Lorenzo; Montico, Marcella; Posocco, Bianca; Corsetti, Serena; Bartoletti, Michele; Gagno, Sara; Orleni, Marco; De Mattia, Elena; Baraldo, Massimo; Cecchin, Erika; Puglisi, Fabio; Toffoli, Giuseppe; Roncato, Rossana | |
| Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival | 1-gen-2026 | Podany, E. L.; Foffano, L.; Gerratana, L.; Medford, A. J.; Heater, N. K.; Nicolo, E.; Tapiavala, S.; Pontolillo, L.; Putur, A.; Jaber, D. A.; Clifton, K.; Katakam, N.; Addison, S.; Lipsyc-Sharf, M.; Reduzzi, C.; Ademuyiwa, F. O.; Puglisi, F.; Gradishar, W. J.; Ma, C. X.; Bardia, A.; Cristofanilli, M.; Davis, A. A. | |
| BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy | 1-gen-2019 | Mio, Catia; Gerratana, Lorenzo; Bolis, Marco; Caponnetto, Federica; Zanello, Andrea; Barbina, Mattia; Di Loreto, Carla; Garattini, Enrico; Damante, Giuseppe; Puglisi, Fabio | |
| Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis | 1-gen-2020 | Bartoletti, M.; Pelizzari, G.; Gerratana, L.; Bortot, L.; Lombardi, D.; Nicoloso, M.; Scalone, S.; Giorda, G.; Baldassarre, G.; Sorio, R.; Puglisi, F. | |
| Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer | 1-gen-2025 | Pasto, B.; Vida, R.; Dri, A.; Foffano, L.; Della Rossa, S.; Gerratana, L.; Puglisi, F. | |
| Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis | 1-gen-2020 | Gerratana, Lorenzo; Basile, Debora; Toffoletto, Barbara; Bulfoni, Michela; Zago, Silvia; Magini, Alessandro; Lera, Marta; Pelizzari, Giacomo; Parisse, Pietro; Casalis, Loredana; Vitale, Maria Grazia; Fanotto, Valentina; Bonotto, Marta; Caponnetto, Federica; Bartoletti, Michele; Lisanti, Camilla; Minisini, Alessandro Marco; Emiliani, Carla; Di Loreto, Carla; Fasola, Gianpiero; Curcio, Francesco; Beltrami, Antonio Paolo; Cesselli, Daniela; Puglisi, Fabio | |
| Body mass index impacts adverse events and drug plasma concentration: should dose intensity be included in the palbociclib equation? | 1-gen-2024 | Roncato, Rossana; Puglisi, Fabio; Gerratana, Lorenzo |